Gianluca Avallone

46PUBLICATIONS
112CO-AUTHORS
Molecular medicineClinical pharmacology and therapeuticsAllergyEpidemiological methodsPharmacology and pharmaceutical sciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (46)

|Nov 25, 2025
Pan-JAK Inhibition Across Chronic Hand Eczema and Other Cutaneous Diseases: An Updated Review on Topical Delgocitinib.

Davide Termini, Gianluca Avallone, Gianluca Tavoletti

|Nov 07, 2025
Dual Biologic Therapy With Dupilumab and Risankizumab for Coexistent Prurigo Nodularis and Psoriasis.

Davide Termini, Gianluca Tavoletti, Gianluca Avallone

|Oct 17, 2025
Phenotypic Switch From Atopic Dermatitis to Psoriasis During Dupilumab Therapy: A Real-Life Experience From a Tertiary Referral Center.

Alessandra Chiei Gallo, Gianluca Tavoletti, Davide Termini

|Oct 10, 2025
Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study.

Gianluca Avallone, Andrea Bombelli, Luigi Gargiulo

|Aug 07, 2025
Romosozumab for Glucocorticosteroid-Induced Osteoporosis in Patients With Autoimmune Blistering Diseases: Primum Non Nocere.

Carlo Alberto Maronese, Gianluca Avallone, Davide Termini

|Jul 15, 2025
Therapeutic outcomes across Janus kinase inhibitors in prurigo nodularis.

Gianluca Avallone, Andrea Bombelli, Luca Valtellini

Pageof 8

Frequent Collaborators

17 joint publications

Simone Ribero

14 joint publications

Angelo Valerio Marzano

11 joint publications

Gianluca Tavoletti

11 joint publications

Carlo Alberto Maronese